Show Summary Details
Page of

Population cancer screening 

Population cancer screening
Population cancer screening

Andrew Evans

, C. Simon Herrington

, and Robert Steele

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 30 July 2021

Population cancer screening is aimed at reducing the burden of disease in a population by the early detection of cancer, and, where possible, by the detection of premalignant disease. For screening to be effective, it is essential that early detection is truly beneficial and does not merely appear to be effective by virtue of lead time and other biases. In this chapter, screening programmes for breast, colorectal, and cervical cancer are covered in detail, and the current status of prostate and lung cancer screening is also considered. Throughout, the emphasis is on the underlying evidence for these interventions, and existing screening strategies are described.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.